证券记录 · 已归档季度
DNLI
Denali Therapeutics Inc. · Healthcare · Biotechnology
17被追踪持有人
+1Δ持有人
74.76M持有股份
$1.05B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +6.2% ·
股份流向 -2.1% ·
净新建仓位 +5.9%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +6 | 103.66M | $2.65B | +11 | −4 |
| Q1 2026 | 93 | +4 | 96.77M | $1.85B | +11 | −8 |
| Q4 2025 | 89 | 0 | 110.68M | $1.83B | +1 | — |
| Q3 2025 | 19 | 0 | 67.26M | $976.61M | — | −1 |
| Q2 2025 | 17 | +1 | 74.76M | $1.05B | +2 | −1 |
| Q1 2025 | 13 | +1 | 44.98M | $611.55M | +2 | −1 |
| Q4 2024 | 12 | -1 | 38.31M | $780.78M | — | −1 |
| Q3 2024 | 12 | 0 | 34.10M | $993.27M | +1 | −1 |
| Q2 2024 | 12 | — | 35.56M | $825.78M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 22 | The Vanguard Group ✦ (被动) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (被动) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (被动) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (被动) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (被动) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 6.58M | +50.7% | $92.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | T. Rowe Price ✦ | 6.58M | +50.7% | $92.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | State Street Global Advisors ✦ (被动) | 4.52M | +1.3% | $63.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 42 | Norges Bank ✦ (被动) | 3.95M | +29.5% | $55.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Geode Capital Management ✦ (被动) | 3.17M | +4.5% | $44.39M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Geode Capital Management ✦ (被动) | 3.17M | +4.5% | $44.39M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Point72 Asset Management ✦ | 2.21M | 新增 | $30.97M | 0.1% | New | 1 | SEC ↗ |
| 46 | Fisher Asset Management ✦ | 1.52M | +11.1% | $21.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Marshall Wace ✦ | 1.41M | -35.8% | $19.66M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | Citadel Advisors ✦ | 1.25M | +6.8% | $17.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 49 | Citadel Advisors ✦ | 1.25M | +6.8% | $17.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 50 | Millennium Management ✦ | 900.50K | -39.7% | $12.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 51 | Renaissance Technologies ✦ | 195.70K | +13.1% | $2.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 21.22K | 新增 | $296,825 | 0.0% | New | 1 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 21.22K | 新增 | $296,825 | 0.0% | New | 1 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 21.22K | 新增 | $296,825 | 0.0% | New | 1 | SEC ↗ |
| 55 | Two Sigma Investments ✦ | 19.30K | -81.2% | $270,007 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $30.97M | 0.1% |
| AQR Capital Management | $296,825 | 0.0% |
| AQR Capital Management | $296,825 | 0.0% |
| AQR Capital Management | $296,825 | 0.0% |
已清仓
| D. E. Shaw & Co. | $1.06M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 265 持有人, 147.10M 股份, $2.60B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 11
Schuth Alexander O.
Officer · 2.86K 股 · $71,625
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 04
SC 13G/A — BAILLIE GIFFORD & CO
Jul 08
SC 13G/A — T. Rowe Price Investment Management…
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据